Ida Tin Coined Femtech; Now She's Funding Continuous Hormone Monitoring

Femtech pioneer Ida Tin is leading a €40 million government-backed challenge, the SPRIND Continuous Hormone Monitoring Challenge, to develop biosensors that can continuously measure at least four hormones over seven days. The initiative, Europe's first such government race, aims to end diagnostic delays that plague women's health conditions like endometriosis (7-10 year diagnosis delay) and PMOS (formerly PCOS, 3-year delay). Tin argues that hormones remain a 'black box' and that modern medicine is built on a male baseline, ignoring hormonal variability. Eight teams are pursuing different technical approaches, from patches to implants, and a shared reference dataset is being created to standardize continuous hormone data across demographics. The challenge seeks to enable precise timing of interventions, particularly for IVF and other reproductive health issues.